On November 2, 2026 Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, reported that the Company will participate in the following investor events during the month of November/this quarter.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Details are as follows:
Guggenheim 3rd Annual Healthcare Innovation Conference
Date: Monday, November 9, 2026
Time: 1:30 PM ET
Webcast Link: https://event.summitcast.com/view/
Stifel 2026 Healthcare Conference
Date: Wednesday, November 11, 2026
Time: 11:20 AM ET
Webcast Link: https://event.summitcast.com/view/
Virtual/Replay availability: Presentations will be archived on Compass’ Events page.
Compass’ management will be available for one-on-one meetings during all events. Interested investors should contact their respective representatives to request meetings.
(Press release, Compass Therapeutics, NOV 2, 2026, View Source [SID1234674044])